Theresa O Hair
Acute Care · Chico, CANPI 1942467519
Payments from drug & device makers
Across 141 payments — averaging $23.65 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Merck$644
- Bayer$407
- Pfizer$382
- Viiv Healthcare Company$337
- Gilead$257
- AbbVie$203
- plus $1K from 18 others
What the payments were for
- Food & beverage$3,324100%
- Education$110%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Merck | 27 | $644 |
| Bayer | 19 | $407 |
| Pfizer | 19 | $382 |
| Viiv Healthcare Company | 13 | $337 |
| Gilead | 6 | $257 |
| AbbVie | 10 | $203 |
| Novo Nordisk | 7 | $199 |
| Daiichi Sankyo Inc. | 7 | $195 |
| Lilly USA, LLC | 7 | $128 |
| Amgen | 5 | $106 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 1 | $84 |
| Indivior Inc. | 3 | $73 |
| Exact Sciences | 3 | $58 |
| AstraZeneca | 3 | $47 |
| Biohaven Pharmaceutical Holding Company Ltd. | 2 | $43 |
| Otsuka America Pharmaceutical, Inc. | 1 | $29 |
| Collegium Pharmaceutical, Inc. | 1 | $24 |
| Viatris Specialty LLC | 1 | $24 |
| Scilex Pharmaceuticals Inc. | 1 | $19 |
| Johnson & Johnson | 1 | $18 |
| GSK | 1 | $18 |
| Phathom Pharmaceuticals, Inc. | 1 | $17 |
| Sanofi Pasteur Inc. | 1 | $17 |
| Dynavax Technologies Corporation | 1 | $8 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Kerendia$109
How this compares
$3,335 in reported general payments places this provider in the 90th percentile of 1,153 acute care providers in California.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| JardianceEmpagliflozin | 121 | $128,850 |
| EliquisApixaban | 48 | $48,761 |
| BiktarvyBictegrav/Emtricit/Tenofov Ala | 11 | $42,564 |
| OzempicSemaglutide | 31 | $32,460 |
| FarxigaDapagliflozin Propanediol | 37 | $28,913 |
| Buprenorphine-NaloxoneBuprenorphine Hcl/Naloxone Hcl | 125 | $19,031 |
| RybelsusSemaglutide | 17 | $16,762 |
| Breo ElliptaFluticasone/Vilanterol | 39 | $14,568 |
| KerendiaFinerenone | 11 | $13,075 |
| TradjentaLinagliptin | 23 | $12,134 |
| Trelegy ElliptaFluticasone/Umeclidin/Vilanter | 11 | $7,116 |
| Atrovent HfaIpratropium Bromide | 11 | $5,102 |
| Pramipexole ErPramipexole Di-Hcl | 12 | $2,842 |
| Dexlansoprazole DrDexlansoprazole | 17 | $2,796 |
| Albuterol Sulfate HfaAlbuterol Sulfate | 99 | $2,369 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Novo NordiskOzempic, Rybelsus | $199 | $49,22248 claims |
| PfizerEliquis | $382 | $48,76148 claims |
| GileadBiktarvy | $257 | $42,56411 claims |
| AstraZenecaFarxiga | $47 | $28,91337 claims |
| GSKBreo Ellipta, Trelegy Ellipta | $18 | $21,68350 claims |
| BayerKerendia | $407 | $13,07511 claims |
| AbbVieSynthroid | $203 | $1,05814 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 1,153 acute care providers in California.
Other acute care in Chico
- Leslie PetersenCamarillo$370K
- Joyce KhremianSan Dimas$73K
- Eleanor VierraSacramento$64K
- Frances DyLos Angeles$57K
- Savannah HarrisVentura$56K
- Kori Ann JohnstonLos Angeles$42K
- Caroline KwongOrange$42K
- Gregory KnutzenColton$41K
- Sunita BoparaiLos Angeles$37K
- Sherona BauLos Angeles$32K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.